Use of Long-Acting Somatostatin Analogue (Lanreotide) in an Adolescent with Diazoxide-Responsive Congenital Hyperinsulinism and Its Psychological Impact

Publisher： Karger

E-ISSN： 1663-2826|84|5|355-360

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.84, Iss.5, 2015-0, pp. : 355-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting Lanreotide in Adolescent Girls with Constitutional Tall Stature

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 4, 2009-03 ,pp. : 228-236

Karger

Access to resources Recommend Favorite

Long-Term Lanreotide Treatment in Six Patients with Congenital Hyperinsulinism

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 2, 2012-08 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant

By  

Neuroendocrinology, Vol. 105, Iss. 1, 2016-07 ,pp. : 44-53

Karger

Access to resources Recommend Favorite

Long-Term Non-Surgical Therapy of Severe Persistent Congenital Hyperinsulinism with Glucagon

By  

Hormone Research in Paediatrics, Vol. 70, Iss. 1, 2008-05 ,pp. : 59-64

Karger

Access to resources Recommend Favorite

Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 Trial

By  

Neuroendocrinology, Vol. 102, Iss. 1-2, 2015-03 ,pp. : 18-25

Karger

Access to resources Recommend Favorite